Medea Inc. Strengthens California's Statewide Strategic PPE Stockpile With Nearly 20 Million N95 Respirators

2025-02-05 01:01:51

(MENAFN- PR Newswire)

PLEASANTON, Calif., Feb. 5, 2025 /PRNewswire/ -- Medea Inc ., a medical products and Pharmaceutical distribution company, fulfilled a contract award by the State of California to supply it with 19.7 million N95 respirators for the State's emergency stockpile. Medea was able to fulfill the contract months ahead of schedule. The contract is part of a five-year Leveraged Procured Agreement (LPA) between the California Department of General Services (DGS) and Medea, which was one of over a hundred suppliers selected by DGS. Any federal, state or local agency may procure N95s in bulk through Medea's LPA .

In 2020, Medea supplied crucial PPE, including more than 26 million N95 respirators and face masks to the Federal Emergency Management Agency (FEMA). Additionally, in 2022, the Department of Defense awarded Medea a $190 million contract for rapid antigen tests.

"We have deep roots in California and stand ready in support of current and future emergency preparedness for our state and local communities," said Brandon Laidlaw, CEO of Medea Inc. "Medea is proud to have delivered all 19.7 million N95 respirators months ahead of schedule."

Medea is a trusted partner of federal, state and local agencies as a distributor of FDA-approved medical products and opioid antagonist drugs.

To learn more, visit medeausa .

About Medea Inc.
Medea Inc., established in 2014 and headquartered in the Silicon Valley Economic Region and Orange County, California, specializes in the distribution of naloxone and other FDA-approved medical products to all levels of government, healthcare and retail channels. Medea also offers expeditious eCommerce product fulfillment services. For more information regarding Medea and its opioid reversal drugs, please visit medeausa .

SOURCE MEDEA

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN05022025003732001241ID1109172774

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.